Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

2(50.0%)

N/A

1(25.0%)

Phase 4

1(25.0%)

4Total

Phase 2(2)

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07500233Phase 2Not Yet Recruiting

Trial of Oral Community SVMP INhibitors for Snakebite

Role: collaborator

NCT06808789Not Yet Recruiting

Mapping Snakebite Risk in Ghana and Rwanda

Role: collaborator

NCT05047666Unknown

COVID-Like Illness Respiratory Pathogens. A Prospective Cohort on the COVID-19 Post-acute Condition

Role: collaborator

NCT04050566Unknown

Malaria Birth Cohort (MBC) in Agogo, Ghana

Role: collaborator

NCT01853657Not ApplicableUnknown

Kumasi Cohort Study

Role: collaborator

NCT01897909Completed

The Impact of Helicobacter Pylori Infection on Immune Regulation and Clinical Course in HIV Patients in Ghana

Role: collaborator

NCT01714414Phase 2Completed

A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen

Role: collaborator

NCT00374205Phase 4Terminated

Randomized Trial on Effectiveness of ACTs in Ghana

Role: collaborator

All 8 trials loaded